Mr. James Howard-Tripp reports

STAGEZERO TO ISSUE Q1 2023 FINANCIAL RESULTS AFTER MARKET CLOSES MAY 15, 2023

Stagezero Life Sciences Ltd. will release its first quarter 2023 operational results after the market closes on Monday, May 15, 2023. Stagezero's chairman and chief executive officer, James Howard-Tripp, will host an investor webcast and conference call at 8:30 a.m. ET on Tuesday, May 16, 2023, reviewing the operational results and discussing business developments.

Analyst and investor call

Event date:  Tuesday, May 16, 2023

Time:  8:30 a.m. ET

Conference call numbers

Canada/United States toll-free:  1-800-319-4610

Toronto toll:  1-416-915-3239

International toll:  1-604-638-5340

About Stagezero Life Sciences Ltd.

Stagezero is a vertically integrated health care company dedicated to improving the early detection and management of cancer and other chronic diseases through next-generation diagnostics and a unique telehealth program that provides clinical interventions to help patients reduce the risk of developing late-stage disease (AVRT).

The company's next-generation test, Aristotle, is the first ever mRNA multicancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the company's patented technology platform, the Sentinel Principle. This underlying technology has been validated in more than 9,000 patients and used by more than 100,000 patients in North America.

Aristotle, as well as additional cancer diagnostics (ColonSentry, BreastSentry and the Prostate Health Index) are processed at the company's clinical laboratory, Stagezero Life Sciences Inc., a CAP (College of American Pathologists)-accredited and CLIA (Clinical Laboratory Improvement Amendments)-certified high-complexity reference laboratory in Richmond, Va. In addition, the company is also leveraging its specialty in polymerase chain reaction (PCR) testing to provide COVID-19 PCR testing (swab and saliva) and antibody testing (blood analysis).

Stagezero trades on the Toronto Stock Exchange under the symbol SZLS and on the OTCQB under the symbol SZLSF.

We seek Safe Harbor.